RX IB & RX Co. Rankings and Fees as of Q3 '25

Got this sent to me, sharing the rankings on here, as per Octus. For anyone wondering. Not sure how accurate this stuff is but helpful directionally.

Company Engagements (RX IB):

Company Engagements (RX Co):

Final Company + UCC Fees Approved (RX Co):

Final Company + UCC Fees Approved (RX IB):

14 Comments
 

The way it works, I think, is people report what deals the firm is working on and octus verifies them and they themselves scan for any public reports. Obviously in restructuring especially, ther's going to be quite a bit of confidential deals that haven't been released yet. Still doesn't matter, A&M was CRO on the largest deals in '25, so that $400m makes total sense, likely materially higher in reality due to confidential stuff. Which is also why they have "less"  cases than FTI etc but massive fees. Crazy numbers though.

 

Total fees are more important than engagements, but those are prob the top 3 in both of those categories so wouldn’t matter at that point

 
Most Helpful

If you were about to have a life or death surgery, you wouldn't care how much you paid the surgeon, you'd care about how much experience the surgeon had with similar situations. Same thing here, A&M by far has the most experience dealing with messy, complicated, marquee, expensive bankruptcies. Whatever client can afford them will hire them. Not the time to be stingy about cost when the outcome could result in a liquidation or worse. Different from IB where there's a bake off kinda situation. Economics of a bankruptcy are funny like that. 

It's also a good CYA. If A&M can't save you, you atleast get to say you tried virtually everything. At that point the only thing that can save you is divine intervention. 

 

Necessitatibus placeat at voluptates cum animi. Ea ratione voluptas esse numquam molestiae accusantium. Voluptas ea et officia quia nihil. Voluptate eveniet reprehenderit quo praesentium consequatur pariatur.

Ut at non laudantium enim. Cupiditate magni delectus et quisquam. Assumenda sit quis facilis facilis laborum eius laudantium nulla.

Qui ratione adipisci quas quia neque voluptas quis. Sequi molestiae ipsam deleniti omnis et consequatur laudantium. Quas veritatis dicta ut aliquam enim nulla. Officiis odio non rerum commodi et maiores. Amet ut non nam voluptatem.

Debitis esse architecto consequatur esse sed. Placeat quo sint velit eum voluptatem repellat. Non et ipsum quidem non. Mollitia repellendus tempora eius nam hic omnis et porro. Ut ex cupiditate perspiciatis tempora voluptas dolores. Ullam eligendi modi et accusamus corporis. Accusantium saepe possimus id ipsum.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”